Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Deloitte
Daiichi Sankyo
US Army
Boehringer Ingelheim
McKesson
Cantor Fitzgerald
Novartis
Dow

Generated: December 11, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Australia Patent: PO 8640

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes► Subscribe► Subscribe► SubscribeTO INHIBIT THE PROLIFERATIVE ACTIVITY OF NEOPLASTIC CELLS
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes► Subscribe► Subscribe► SubscribeTO INHIBIT THE PROLIFERATIVE ACTIVITY OF NEOPLASTIC CELLS
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes► Subscribe► Subscribe► SubscribeTO STIMULATE THE IMMUNE SYSTEM TO INDUCE T CELL PROLIFERATION
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes► Subscribe► Subscribe► SubscribeTO STIMULATE THE IMMUNE SYSTEM TO INDUCE T CELL PROLIFERATION
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes► Subscribe► Subscribe► SubscribeTREATMENT OF ACTINIC KERATOSIS
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes► Subscribe► Subscribe► SubscribeTREATMENT OF ACTINIC KERATOSIS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist